Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
Jim Weiss: Make It Happen
Ziihera Plus Chemotherapy Improves Overall Survival in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma
HUTCHMED Reports Positive Phase 3 SANOVO Results for Savolitinib Plus Osimertinib in EGFR-Mutated NSCLC
By Women, for Women: The Untold Stories at the Roots of Oncology
An Appeal for Solidarity, Compassion, and Support for Nepal’s Ongoing Rescue and Recovery Efforts
The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
Pashtoon Kasi: Lessons from the NEST Phase 2 Trial in Colon Cancer
The HSCO 2026 Annual Conference, organized by the Hawaii Society of Clinical Oncology (HSCO), will take place on November 14, 2026, from 7:30 AM to 4:30 PM HST, at the Kahala Resort and Hotel in Honolulu, Hawaii. The in-person conference will bring together oncology professionals from across Hawaii to discuss local healthcare disparities, emerging cancer […]
